Arbutus Presents Data on HBV Capsid Assembly Inhibitor AB-423 at EASL 2016
Apr 14, 2016 12:00 pm UTC| Business
Synergistic Antiviral Activity When Combining AB-423 With EntecavirIND Filing (or Equivalent) Expected in the Second Half of 2016 VANCOUVER, British Columbia and DOYLESTOWN, Pa., April 14, 2016 -- Arbutus Biopharma...
Vocera Q1 2016 Results to be Released April 28, 2016
Apr 14, 2016 12:00 pm UTC| Business
SAN JOSE, Calif., April 14, 2016 -- Vocera Communications, Inc.(NYSE:VCRA) today announced that it expects to release results for its first quarter 2016 on Thursday, April 28, after market close.In conjunction with a...
Apr 14, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., April 14, 2016 -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that new data from a pharmacokinetic modeling study designed to identify the dose of cerdulatinib for expansion...
Encore Capital Renews Commitment to Financial Literacy as a National Partner of Jump$tart
Apr 14, 2016 12:00 pm UTC| Business
SAN DIEGO, April 14, 2016 -- Encore Capital Group, Inc. (NASDAQ:ECPG), an international specialty finance company, announced it has renewed its commitment to financial literacy as a national partner with Jump$tart...
SITO Mobile Launches Real-time In-store Attribution
Apr 14, 2016 12:00 pm UTC| Business
JERSEY CITY, N.J., April 14, 2016 -- SITO Mobile Ltd. (SITO) (NASDAQ:SITO), a leading mobile engagement platform provider, announced today the launch of Real-time Verified Walk-In (VWI), a proprietary technology that...
Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016
Apr 14, 2016 12:00 pm UTC| Business
CAMBRIDGE, Mass., April 14, 2016 -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company developing life-changing treatments for severe diseases of the central nervous system (CNS), today...
Apr 14, 2016 12:00 pm UTC| Business
SB 9200 followed by entecavir resulted in significant declines in viral DNA, RNA and surface antigens in the woodchuck model of HBV; results support advancement of SB 9200 to Phase 2 in HBV SB 9200 inhibited the...